Chimerix Inc (CMRX) concluded trading on Wednesday at a closing price of $8.46, with 118.5 million shares of worth about $1.0 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 807.63% during that period and on March 05, 2025 the price saw a gain of about 70.56%. Currently the company’s common shares owned by public are about 89.94M shares, out of which, 76.06M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of 83.91% in past 5 days and over the past one month there was a price change of 122.63%. Year-to-date (YTD), CMRX shares are showing a performance of 143.10% which increased to 623.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.75 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Chimerix Inc shares is 5.29 million. The stock is currently trading 74.78% above its 20-day simple moving average (SMA20), while that difference is up 107.08% for SMA50 and it goes to 378.38% higher than SMA200.
Chimerix Inc (NASDAQ: CMRX) currently have 89.94M outstanding shares and institutions hold larger chunk of about 46.48% of that.
The stock has a current market capitalization of $760.85M and its 3Y-monthly beta is at 0.15. It has posted earnings per share of -$0.94 in the same period. It has Quick Ratio of 6.33 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CMRX, volatility over the week remained 8.34% while standing at 7.49% over the month.
Analysts are in expectations that Chimerix Inc (CMRX) stock would likely to be making an EPS of -0.28 in the current quarter, while forecast for next quarter EPS is -0.29 and it is -1.29 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.31 which is -0.24 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.2 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -6.24% while it is estimated to decrease by -17.41% in next year. EPS is likely to grow at an annualized rate of 9.30% for next 5-years, compared to annual growth of 8.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on May 23, 2023 offering an Outperform rating for the stock and assigned a target price of $7 to it. Coverage by CapitalOne stated Chimerix Inc (CMRX) stock as an Overweight in their note to investors on September 07, 2022, suggesting a price target of $7 for the stock. On April 29, 2021, Maxim Group Initiated their recommendations, while on April 23, 2021, Cowen Resumed their ratings for the stock with a price target of $18. Stock get an Outperform rating from Wedbush on March 31, 2021.
